Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05782816 · ClinicalTrials.gov registry record · Phase 4
Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor
A Phase 4 study of Labor Long, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 4
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT05782816: Completed Phase 4 study of Labor Long, sponsored by The University of Texas Medical Branch, Galveston.
NCT05782816 is a Phase 4 study of Labor Long that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 170 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05782816, a Phase 4 study of Labor Long, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question\[s\] it aims to answer are: * Does a high dose oxytocin infusion protocol affect length of induction to delivery interval? * Does a high dose oxytocin infusion protocol affect mode of delivery? * Does a high dose oxytocin infusion protocol affect maternal and neonatal outcomes? Participants will be randomized to either low- or high-dose oxytocin groups: * The low dose group will receive an infusion to start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. The maximum rate of infusion is 40 milli-units/min. * The high dose group will receive an infusion to start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min.
Primary Outcome
Induction to delivery time interval
Conditions Studied
Interventions
- DRUG Oxytocin (Low dose)
- DRUG Oxytocin (High dose)
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2025-06-24 |
| Phase | Phase 4 |
What the finished NCT05782816 record still lists
NCT05782816 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Labor Long appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin (Low dose) is the first listed.
NCT05782816 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05782816 about?
NCT05782816 is a clinical study titled "Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor". The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question\[s\] it aims to answer are: * Does a high dose oxytocin infusion protocol affect length of induction to delivery interval? * Does a high dose oxytoci...
What is the current status of trial NCT05782816?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 170 participants. The study started on 2023-04-17. Estimated completion is 2025-06-24.
What conditions does trial NCT05782816 study?
This clinical trial studies the following conditions: Labor Long.
What interventions are being tested in trial NCT05782816?
The interventions under investigation include: Oxytocin (Low dose) (DRUG), Oxytocin (High dose) (DRUG).
Who is sponsoring clinical trial NCT05782816?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05782816 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor Long
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05782816's enrollment target sits among peer trials
170 484th of 2000 higher than 1,514 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI